Vaxil Bio Ltd (VXL) — Cash Flow-to-Debt Ratio
Vaxil Bio Ltd (VXL) has a Cash Flow-to-Debt Ratio of -3.50x as of September 2025, meaning its operating cash flow of CA$-28.00K could theoretically repay -4% of its total liabilities (CA$8.00K) in one year. See Vaxil Bio Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vaxil Bio Ltd Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Vaxil Bio Ltd across 16 annual periods. Also explore VXL net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Vaxil Bio Ltd (2009–2024)
Year-by-year debt coverage analysis for Vaxil Bio Ltd. For market capitalisation and broader financial context, see VXL market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -14.12x | CA$-240.00K | CA$17.00K | ▼ -113.9% |
| 2023 | -6.60x | CA$-561.00K | CA$85.00K | ▼ -264.2% |
| 2022 | -1.81x | CA$-734.00K | CA$405.00K | ▲ +2.2% |
| 2021 | -1.85x | CA$-1.08 Million | CA$585.00K | ▼ -44.0% |
| 2020 | -1.29x | CA$-1.10 Million | CA$857.00K | ▼ -70.2% |
| 2019 | -0.76x | CA$-596.00K | CA$788.00K | ▲ +63.5% |
| 2018 | -2.07x | CA$-943.00K | CA$455.00K | ▼ -65.0% |
| 2017 | -1.26x | CA$-1.00 Million | CA$797.00K | ▲ +53.0% |
| 2016 | -2.67x | CA$-1.50 Million | CA$561.00K | ▼ -117.0% |
| 2015 | -1.23x | CA$-624.00K | CA$507.00K | ▲ +22.3% |
| 2014 | -1.58x | CA$-128.91K | CA$81.35K | ▲ +73.1% |
| 2013 | -5.90x | CA$-383.44K | CA$64.99K | ▼ -614.5% |
| 2012 | -0.83x | CA$-164.34K | CA$199.02K | ▲ +82.1% |
| 2011 | -4.62x | CA$-457.76K | CA$99.17K | ▲ +53.6% |
| 2010 | -9.96x | CA$-380.10K | CA$38.17K | ▼ -99.3% |
| 2009 | -5.00x | CA$-145.03K | CA$29.03K | — |